Article reviewed and compared the costs and access to novel drugs for treating chronic lymphocytic leukemia and lymphoma in the United States and India during the last 5 years.
Home / Resource Library / Comparison of Access to Novel Drugs for Lymphoma and Chronic Lymphocytic Leukemia Between India and the United States